Company · CIK 0000882095 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
GILEAD SCIENCES, INC. · GILD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 5, 2015 MForm 4 → | May 7, 5:18 pm EDT | Gayle E WilsonDirector | 1,904 | — | — | 42,769 | — | plan? |
| May 5, 2015 MForm 4 → | May 7, 5:16 pm EDT | John Francis CoganDirector | 1,904 | — | — | 44,309 | — | plan? |
| May 5, 2015 MForm 4 → | May 7, 5:14 pm EDT | Olsen Per WoldDirector | 1,904 | — | — | 90,077 | — | plan? |
| May 5, 2015 MForm 4 → | May 7, 5:14 pm EDT | Richard James WhitleyDirector | 23,624 | $19.63 | $426,364 | 39,265 | — | plan? |
| May 5, 2015 MForm 4 → | May 7, 5:12 pm EDT | Carla A HillsDirector | 1,904 | — | — | 37,819 | — | plan? |
| May 1, 2015 SForm 4 → | May 5, 7:38 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 12,000 | $104.07 | $1,248,871 | 143,422 | −7.72% | plan? |
| May 1, 2015 MForm 4 → | May 5, 7:38 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 10,000 | $19.09 | $190,850 | 155,422 | — | plan? |
| May 1, 2015 SForm 4 → | May 5, 7:38 pm EDT | Robin L WashingtonEVP, CFO | 16,842 | $105.06 | $1,769,405 | 27,724 | −37.8% | plan? |
| May 1, 2015 MForm 4 → | May 5, 7:38 pm EDT | Robin L WashingtonEVP, CFO | 16,842 | $29.70 | $500,130 | 44,566 | — | plan? |
| May 1, 2015 SForm 4 → | May 5, 5:47 pm EDT | John C MartinChairman and CEO, Director | 150,000 | $104.95 | $15,742,491 | 4,255,876 | −3.40% | plan? |
| May 1, 2015 MForm 4 → | May 5, 5:47 pm EDT | John C MartinChairman and CEO, Director | 150,000 | $14.50 | $2,175,375 | 4,405,876 | — | plan? |
| May 1, 2015 SForm 4 → | May 5, 4:23 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 2,000 | $103.18 | $206,365 | 45,439 | −4.22% | plan? |
| May 1, 2015 MForm 4 → | May 5, 4:23 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 2,000 | $80.65 | $161,300 | 47,439 | — | plan? |
| Apr 15, 2015 SForm 4 → | Apr 17, 2:23 pm EDT | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $103.84 | $7,268,627 | 165,168 | −29.8% | plan? |
| Apr 15, 2015 MForm 4 → | Apr 17, 2:23 pm EDT | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $20.74 | $1,451,800 | 235,168 | — | plan? |
| Apr 8, 2015 SForm 4 → | Apr 9, 4:40 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | $100.00 | $500,000 | 145,422 | −3.32% | plan? |
| Apr 8, 2015 MForm 4 → | Apr 9, 4:40 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | $19.09 | $95,425 | 150,422 | — | plan? |
| Apr 8, 2015 SForm 4 → | Apr 9, 4:40 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $100.00 | $100,000 | 45,439 | −2.15% | plan? |
| Apr 8, 2015 MForm 4 → | Apr 9, 4:40 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $80.65 | $80,650 | 46,439 | — | plan? |
| Apr 1, 2015 SForm 4 → | Apr 3, 5:24 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $98.04 | $98,044 | 45,439 | −2.15% | plan? |
| Apr 1, 2015 MForm 4 → | Apr 3, 5:24 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $80.65 | $80,650 | 46,439 | — | plan? |
| Apr 1, 2015 SForm 4 → | Apr 3, 5:24 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 7,000 | $96.53 | $675,715 | 145,422 | −4.59% | plan? |
| Apr 1, 2015 MForm 4 → | Apr 3, 5:24 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | $19.09 | $95,425 | 152,422 | — | plan? |
| Apr 1, 2015 SForm 4 → | Apr 3, 5:24 pm EDT | John C MartinChairman and CEO, Director | 150,000 | $96.74 | $14,511,463 | 4,255,876 | −3.40% | plan? |
| Apr 1, 2015 MForm 4 → | Apr 3, 5:24 pm EDT | John C MartinChairman and CEO, Director | 150,000 | $14.50 | $2,175,375 | 4,405,876 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 7:39 pm EDT | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $100.80 | $7,056,206 | 165,168 | −29.8% | plan? |
| Mar 16, 2015 MForm 4 → | Mar 18, 7:39 pm EDT | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $19.50 | $1,364,900 | 235,168 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:49 pm EST | Paul Rutherford CarterEVP Commercial Ops | 2,000 | $104.18 | $208,364 | 45,439 | −4.22% | plan? |
| Mar 2, 2015 MForm 4 → | Mar 4, 7:49 pm EST | Paul Rutherford CarterEVP Commercial Ops | 2,000 | $80.65 | $161,300 | 47,439 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:49 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 12,000 | $103.63 | $1,243,615 | 147,422 | −7.53% | plan? |
| Mar 2, 2015 MForm 4 → | Mar 4, 7:49 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 10,000 | $19.09 | $190,850 | 159,422 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:48 pm EST | John C MartinChairman and CEO, Director | 150,000 | $103.51 | $15,526,245 | 4,255,876 | −3.40% | plan? |
| Mar 2, 2015 MForm 4 → | Mar 4, 7:48 pm EST | John C MartinChairman and CEO, Director | 150,000 | $14.50 | $2,175,375 | 4,405,876 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 3, 4:12 pm EST | Richard James WhitleyDirector | 5,000 | $103.43 | $517,136 | 15,641 | −24.2% | plan? |
| Mar 2, 2015 MForm 4 → | Mar 3, 4:12 pm EST | Richard James WhitleyDirector | 5,000 | $26.99 | $134,950 | 20,641 | — | plan? |
| Mar 1, 2015 MForm 4 → | Mar 3, 4:11 pm EST | Nicholas G MooreDirector | 167 | — | — | 15,119 | — | plan? |
| Feb 26, 2015 AGForm 4 → | Feb 27, 5:02 pm EST | Robin L WashingtonEVP, CFO | 115,264 | — | — | 101,471 | — | plan? |
| Feb 17, 2015 SForm 4 → | Feb 19, 6:42 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $103.01 | $7,210,740 | 165,168 | −29.8% | plan? |
| Feb 17, 2015 MForm 4 → | Feb 19, 6:42 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $16.40 | $1,147,650 | 235,168 | — | plan? |
| Feb 13, 2015 AFForm 4 → | Feb 19, 6:36 pm EST | John F MilliganPresident and COO | 269,000 | $103.80 | $11,128,997 | 1,029,108 | — | plan? late |
| Feb 13, 2015 AFForm 4 → | Feb 19, 6:36 pm EST | John C MartinChairman and CEO, Director | 621,299 | $103.82 | $25,379,479 | 4,255,876 | — | plan? late |
| Feb 13, 2015 AFForm 4 → | Feb 19, 6:35 pm EST | Robin L WashingtonEVP, CFO | 160,756 | $103.77 | $6,523,277 | 85,356 | — | plan? late |
| Feb 13, 2015 AFForm 4 → | Feb 19, 6:34 pm EST | Paul Rutherford CarterEVP Commercial Ops | 43,445 | $103.56 | $1,698,975 | 45,439 | — | plan? late |
| Feb 13, 2015 AFForm 4 → | Feb 19, 6:32 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 212,846 | $103.79 | $8,690,833 | 165,168 | — | plan? late |
| Feb 13, 2015 AFForm 4 → | Feb 19, 6:31 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 171,316 | $103.77 | $6,957,121 | 149,422 | — | plan? late |
| Feb 6, 2015 PForm 4 → | Feb 10, 4:30 pm EST | Olsen Per WoldDirector | 10,000 | $99.92 | $999,150 | 88,173 | +12.8% | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 8:52 pm EST | Paul Rutherford CarterEVP Commercial Ops | 2,000 | $106.15 | $212,310 | 34,308 | −5.51% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:52 pm EST | Paul Rutherford CarterEVP Commercial Ops | 2,000 | $80.65 | $161,300 | 36,308 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 8:52 pm EST | Robin L WashingtonEVP, CFO | 33,192 | $105.38 | $3,497,662 | 49,832 | −40.0% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:52 pm EST | Robin L WashingtonEVP, CFO | 33,192 | $25.14 | $834,586 | 83,024 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 8:51 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 12,000 | $105.73 | $1,268,719 | 111,694 | −9.70% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:51 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 10,000 | $19.09 | $190,850 | 123,694 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 8:15 pm EST | John C MartinChairman and CEO, Director | 150,000 | $105.43 | $15,815,249 | 4,122,987 | −3.51% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:15 pm EST | John C MartinChairman and CEO, Director | 150,000 | $14.50 | $2,175,375 | 4,272,987 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:04 pm EST | Richard James WhitleyDirector | 5,000 | $105.67 | $528,358 | 15,641 | −24.2% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:04 pm EST | Richard James WhitleyDirector | 5,000 | $26.99 | $134,950 | 20,641 | — | plan? |
| Jan 15, 2015 SForm 4 → | Jan 20, 12:46 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $98.47 | $6,893,083 | 119,302 | −37.0% | plan? |
| Jan 15, 2015 MForm 4 → | Jan 20, 12:46 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | $16.40 | $1,147,650 | 189,302 | — | plan? |
| Jan 8, 2015 SForm 4 → | Jan 12, 3:55 pm EST | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $100.88 | $100,881 | 34,308 | −2.83% | plan? |
| Jan 8, 2015 MForm 4 → | Jan 12, 3:55 pm EST | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $36.72 | $36,720 | 35,308 | — | plan? |
| Jan 8, 2015 SForm 4 → | Jan 12, 3:06 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | $100.89 | $504,450 | 113,694 | −4.21% | plan? |
| Jan 8, 2015 MForm 4 → | Jan 12, 3:06 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | $19.09 | $95,425 | 118,694 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 4:21 pm EST | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $95.05 | $95,050 | 34,308 | −2.83% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 6, 4:21 pm EST | Paul Rutherford CarterEVP Commercial Ops | 1,000 | $40.56 | $40,560 | 35,308 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 4:20 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 7,000 | $95.17 | $666,192 | 113,694 | −5.80% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 6, 4:20 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | $19.09 | $95,425 | 120,694 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 4:20 pm EST | John C MartinChairman and CEO, Director | 150,000 | $95.12 | $14,267,387 | 4,122,987 | −3.51% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 6, 4:20 pm EST | John C MartinChairman and CEO, Director | 150,000 | $14.50 | $2,175,375 | 4,272,987 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 2:12 pm EST | Richard James WhitleyDirector | 5,000 | $95.22 | $476,100 | 15,641 | −24.2% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 6, 2:12 pm EST | Richard James WhitleyDirector | 5,000 | $26.99 | $134,950 | 20,641 | — | plan? |
| Dec 22, 2014 GForm 4 → | Jan 5, 2015, 1:22 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 1,000 | — | — | 115,694 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 5, 2015 AMForm 4 → | May 7, 5:19 pm EDT | Etienne DavignonDirector | 8,537 | — | — | 5,167 | — | |
| May 5, 2015 AMForm 4 → | May 7, 5:18 pm EDT | John W MadiganDirector | 8,537 | — | — | 5,167 | — | |
| May 5, 2015 AMForm 4 → | May 7, 5:18 pm EDT | Gayle E WilsonDirector | 8,537 | — | — | 5,167 | — | |
| May 5, 2015 AMForm 4 → | May 7, 5:16 pm EDT | John Francis CoganDirector | 8,537 | — | — | 5,167 | — | |
| May 5, 2015 AMForm 4 → | May 7, 5:14 pm EDT | Olsen Per WoldDirector | 8,537 | — | — | 5,167 | — | |
| May 5, 2015 AMForm 4 → | May 7, 5:14 pm EDT | Richard James WhitleyDirector | 30,257 | — | — | 5,167 | — | |
| May 5, 2015 AMForm 4 → | May 7, 5:12 pm EDT | Carla A HillsDirector | 8,537 | — | — | 5,167 | — | |
| May 1, 2015 MForm 4 → | May 5, 7:38 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 10,000 | — | — | 24,375 | — | |
| May 1, 2015 MForm 4 → | May 5, 7:38 pm EDT | Robin L WashingtonEVP, CFO | 16,842 | — | — | 39,158 | — | |
| May 1, 2015 MForm 4 → | May 5, 5:47 pm EDT | John C MartinChairman and CEO, Director | 150,000 | — | — | 1,050,000 | — | |
| May 1, 2015 MForm 4 → | May 5, 4:23 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 2,000 | — | — | 30,640 | — | |
| Apr 15, 2015 MForm 4 → | Apr 17, 2:23 pm EDT | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | — | — | 20,000 | — | |
| Apr 8, 2015 MForm 4 → | Apr 9, 4:40 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | — | — | 34,375 | — | |
| Apr 8, 2015 MForm 4 → | Apr 9, 4:40 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 1,000 | — | — | 32,640 | — | |
| Apr 1, 2015 MForm 4 → | Apr 3, 5:24 pm EDT | Paul Rutherford CarterEVP Commercial Ops | 1,000 | — | — | 33,640 | — | |
| Apr 1, 2015 MForm 4 → | Apr 3, 5:24 pm EDT | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | — | — | 39,375 | — | |
| Apr 1, 2015 MForm 4 → | Apr 3, 5:24 pm EDT | John C MartinChairman and CEO, Director | 150,000 | — | — | 1,200,000 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 7:39 pm EDT | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | — | — | 90,000 | — | |
| Mar 2, 2015 MForm 4 → | Mar 4, 7:49 pm EST | Paul Rutherford CarterEVP Commercial Ops | 2,000 | — | — | 34,640 | — | |
| Mar 2, 2015 MForm 4 → | Mar 4, 7:49 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 10,000 | — | — | 44,375 | — | |
| Mar 2, 2015 MForm 4 → | Mar 4, 7:48 pm EST | John C MartinChairman and CEO, Director | 150,000 | — | — | 1,350,000 | — | |
| Mar 2, 2015 MForm 4 → | Mar 3, 4:12 pm EST | Richard James WhitleyDirector | 5,000 | — | — | 0 | — | |
| Mar 1, 2015 MForm 4 → | Mar 3, 4:11 pm EST | Nicholas G MooreDirector | 167 | — | — | 23,728 | — | |
| Feb 17, 2015 MForm 4 → | Feb 19, 6:42 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | — | — | 20,000 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:52 pm EST | Paul Rutherford CarterEVP Commercial Ops | 2,000 | — | — | 36,640 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:52 pm EST | Robin L WashingtonEVP, CFO | 33,192 | — | — | 44,750 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:51 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 10,000 | — | — | 54,375 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 8:15 pm EST | John C MartinChairman and CEO, Director | 150,000 | — | — | 1,500,000 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:04 pm EST | Richard James WhitleyDirector | 5,000 | — | — | 5,000 | — | |
| Feb 1, 2015 AForm 4 → | Feb 3, 9:50 pm EST | John C MartinChairman and CEO, Director | 169,820 | — | — | 169,820 | — | |
| Feb 1, 2015 AForm 4 → | Feb 3, 9:50 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 51,690 | — | — | 51,690 | — | |
| Feb 1, 2015 AForm 4 → | Feb 3, 9:49 pm EST | John F MilliganPresident and COO | 70,290 | — | — | 70,290 | — | |
| Feb 1, 2015 AForm 4 → | Feb 3, 9:49 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 62,020 | — | — | 62,020 | — | |
| Feb 1, 2015 AForm 4 → | Feb 3, 9:49 pm EST | Robin L WashingtonEVP, CFO | 47,260 | — | — | 47,260 | — | |
| Feb 1, 2015 AForm 4 → | Feb 3, 9:48 pm EST | Paul Rutherford CarterEVP Commercial Ops | 44,300 | — | — | 44,300 | — | |
| Jan 15, 2015 MForm 4 → | Jan 20, 12:46 pm EST | Norbert W BischofbergerEVP, R&D and CSO | 70,000 | — | — | 90,000 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 3:55 pm EST | Paul Rutherford CarterEVP Commercial Ops | 1,000 | — | — | 17,523 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 3:06 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | — | — | 64,375 | — | |
| Jan 2, 2015 MForm 4 → | Jan 6, 4:21 pm EST | Paul Rutherford CarterEVP Commercial Ops | 1,000 | — | — | 18,240 | — | |
| Jan 2, 2015 MForm 4 → | Jan 6, 4:20 pm EST | Gregg H AltonEVP, Corp & Med Affairs | 5,000 | — | — | 69,375 | — | |
| Jan 2, 2015 MForm 4 → | Jan 6, 4:20 pm EST | John C MartinChairman and CEO, Director | 150,000 | — | — | 1,650,000 | — | |
| Jan 2, 2015 MForm 4 → | Jan 6, 2:12 pm EST | Richard James WhitleyDirector | 5,000 | — | — | 10,000 | — |